abstract |
The invention provides an HPK1 kinase inhibitor and its preparation and use. Specifically, the present invention provides a compound represented by formula I, wherein the definitions of each group are as described in the specification. The compound has excellent HPK1 inhibitory activity, so it can be used to prepare a pharmaceutical composition for treating cancer and other diseases related to HPK1 activity. |